Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-24-010709

Chief Financial Officer acquired 31,260 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PISKEL KYLE · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-15 Grant or award : show line 1 in the form +31,260 154,578 D
Loading xslF345X05/form4.xml…